Tenax Therapeutics, Inc.
TENX
$6.00
-$0.04-0.66%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 105.46M | 111.45M | 94.85M | 98.31M | 9.38M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 395.00K | 524.00K | 1.77M | 1.44M | 1.18M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | 88.00K | 64.00K | 33.90K | 50.30K |
Total Current Assets | 105.86M | 112.06M | 96.69M | 99.78M | 10.62M |
|
|||||
Total Current Assets | 105.86M | 112.06M | 96.69M | 99.78M | 10.62M |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | 1.10K | 1.10K |
Total Assets | 105.86M | 112.06M | 96.69M | 99.78M | 10.62M |
|
|||||
Total Accounts Payable | 562.00K | 1.84M | 3.16M | 1.58M | 869.70K |
Total Accrued Expenses | 1.97M | 929.00K | 1.54M | 977.50K | 592.40K |
Short-term Debt | -- | -- | -- | -- | 278.80K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 2.53M | 2.77M | 4.69M | 2.56M | 1.74M |
|
|||||
Total Current Liabilities | 2.53M | 2.77M | 4.69M | 2.56M | 1.74M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | 278.80K |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 2.53M | 2.77M | 4.69M | 2.56M | 1.74M |
|
|||||
Common Stock & APIC | 439.44M | 434.55M | 406.85M | 405.81M | 313.50M |
Retained Earnings | -336.11M | -325.26M | -314.86M | -308.59M | -304.63M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 103.33M | 109.29M | 91.99M | 97.22M | 8.88M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 103.33M | 109.29M | 91.99M | 97.22M | 8.88M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 103.33M | 109.29M | 91.99M | 97.22M | 8.88M |
|